USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Search results for: 'software revenue m8de'
- Did you mean
- software revenue more
- software revenue model
- Related search terms
- Software-Defined Instruments and Reinvented Business Models to Impact Market Outlook, Communication Test Revenues to Soar
- Software-as-a-Service Value Proposition - A Look Under the Hood
- revenue opportunities in Europe Charging Infrastructure
- m8de based system engineering market
- m8de based engineering market
-
This research service analyzes the market for diabetes in vitro diagnostics within the United States. This service covers market trends, technology trends, competitive structure, revenue forecasts, market drivers and restraints. The key challenges and strategies are also covered.
$4,950.00 -
13 Jul 2012 | Europe | Market Research
European Diabetes Diagnostics Market
Growing Diabetes Prevalence Drives Demand
The aim of this research service is to analyse the diabetes diagnostics market in Europe and provide strategic recommendations and conclusions for the success of its participants. The main objective of this research service is to establish an understanding of the key diabetes diagnostics market segments (laboratory-based HbA1C diagnostics, SMBG and...
$4,950.00 -
19 Dec 2013 | Global | Market Research
Trends, Opportunities, and Challenges for the Latin American Diabetes Therapeutics Market
Innovative Drugs to Launch in the Next 3 Years, Impacting the Insulin and Non-insulin Markets
Biomarkers are no longer mere tools used to measure the criteria of a biological process characteristic. They are being increasingly used in patient stratification and customised medical interventions. This research service presents an overview and analysis of the global biomarker market. It provides revenue forecasts for biomarker on technological...
$2,450.00 -
This research service studies the Indian Diabetes market. It provides the number of Type 1 and Type 2 diabetic patients in India across different age groups and forecasts these numbers up to 2030. It provides a detailed analysis of the two major segments of the market, the insulin market segment and the anti-diabetic medications segment, which incl...
$4,950.00
